Michael John Reed

Title: Michael John Reed: Innovator in Diabetes Treatment

Introduction

Michael John Reed is a notable inventor based in Menlo Park, California. He has made significant contributions to the field of diabetes treatment through his innovative research and development. His work focuses on the discovery and application of novel compounds that can aid in managing diabetes.

Latest Patents

Michael John Reed holds a patent for a triterpenoid compound specifically designed for the treatment of diabetes. This patent describes a novel hypoglycemically active triterpenoid compound isolated in purified form from Salacia spp. The patent outlines processes for obtaining this compound, as well as compositions that include the triterpenoid and methods for its use as a hypoglycemic agent. In particular, the triterpenoid compound is derived from Salacia prinoides and is effective for treating both insulin-dependent (type I) and non-insulin-dependent (type II) diabetes.

Career Highlights

Michael John Reed is associated with Shaman Pharmaceuticals, Inc., where he has been instrumental in advancing research related to diabetes treatment. His work has not only contributed to scientific knowledge but also holds potential for practical applications in healthcare.

Collaborations

Michael has collaborated with Wayne D Inman, further enhancing the research and development efforts at Shaman Pharmaceuticals, Inc. Their partnership exemplifies the importance of teamwork in the field of innovation.

Conclusion

Michael John Reed's contributions to diabetes treatment through his patented triterpenoid compound highlight his role as an innovator in the medical field. His work continues to pave the way for advancements in diabetes management.